Description
INCREASE FUNDING FOR FY 24 TO SUPPORT CLOSEOUT
Base award description: PYLARIFY (PIFLUFOLASTAT F-18)
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-06-18+$541,308= $541,308
- Mod P000012024-06-20+$0= $541,308
- Mod P000022025-02-19+$270,654= $811,962
- Mod P000032025-06-18+$72,174= $884,136
- Mod P000042025-06-30+$0= $884,136
- Mod P000052025-08-01+$144,349= $1,028,485
- Mod P000062026-03-25+$1,200= $1,029,685
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-06-18 | +$541,308 | $541,308 | PYLARIFY (PIFLUFOLASTAT F-18) |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-06-20 | +$0 | $541,308 | ADMINISTRATIVE CHANGE |
| Mod P00002· FUNDING ONLY ACTION | 2025-02-19 | +$270,654 | $811,962 | INCREASE FUNDING FOR FY 24 |
| Mod P00003· EXERCISE AN OPTION | 2025-06-18 | +$72,174 | $884,136 | INCREASE FUNDING FOR FY 24 |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2025-06-30 | +$0 | $884,136 | INCREASE FUNDING FOR FY 24 |
| Mod P00005· FUNDING ONLY ACTION | 2025-08-01 | +$144,349 | $1,028,485 | INCREASE FUNDING FOR FY 24 |
| Mod P00006· FUNDING ONLY ACTION | 2026-03-25 | +$1,200 | $1,029,685 | INCREASE FUNDING FOR FY 24 TO SUPPORT CLOSEOUT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI YLYKVRPCTCR3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24626N0890 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $1,212,530 | FY2026 |
| 36C24626A0027 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26226F0313 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $180,436 | FY2026 |
| 36C25026N0655 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $721,744 | FY2026 |
| 36C26026F0298 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $469,134 | FY2026 |
| 36C25026N0531 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $559,352 | FY2026 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0376 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $233,435 | FY2026 |
| 36C25526N0394 | NOVARTIS PHARMACEUTICALS CORPORATION | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $891,651 | FY2026 |
| 36C25526N0392 | SOFIE CO. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $357,066 | FY2026 |
| 36C25526N0361 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $228,679 | FY2026 |
| 36C25526D0057 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25524N0303_3600_36F79719D0170_3600 · retrieved 2026-09-26.